New Drug Approvals From FDA Declined in 2013

02-01-2014 Motley FoolComments (0)

PharmaceuticalVanda Pharmaceuticals

... of 2014 the FDA is scheduled to rule on several innovative medications, including a long-lasting injectable drug for hemophilia from Biogen Idec and the first-ever treatment for a sleep disorder caused by blindness, developed by Vanda Pharmaceuticals.

Read more on Motley Fool

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top